News & Events about Homology Medicines Inc.
Globe Newswire
3 months ago
BEDFORD, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Julie Jordan, M.D., has been promoted to Chief Medical Officer. Previously, Dr. Jordan held the role of Senior Vice President, Head of Clinical Development ...
Globe Newswire
3 months ago
PHILADELPHIA, March 06, 2023 (GLOBE NEWSWIRE) -- Investor protection law firm Kaskela Law LLC announces that it is investigating Homology Medicines, Inc. (Homology or the Company) (NASDAQ: FIXX) on behalf of the Companys long-term stockholders. Recently an amended securities fraud complaint was ...
Globe Newswire
3 months ago
BEDFORD, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Albert Seymour, Ph.D., President and Chief Executive Officer, will participate inthe Gene Editing Corporate Panel during the 43rd Annual Cowen Healthcare ...
Ticker Report
4 months ago
Homology Medicines, Inc. (NASDAQ:FIXX Get Rating) has received a consensus rating of Moderate Buy from the ten brokerages that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and six have given a buy ...
Globe Newswire
5 months ago
PHILADELPHIA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Homology Medicines, Inc. (Homology or the Company) (NASDAQ: FIXX) on behalf of the Companys long-term investors. Recently an amended securities fraud complaint was filed against Homology on behalf of ...